HEV重叠感染加速慢性HBV感染患者疾病进展并增加肝硬化患者死亡率
研究基于两个独立回顾性队列(非肝硬化2123例、肝硬化414例)探讨HEV重叠感染对慢性HBV感染患者结局的影响。结果显示HEV重叠感染增加肝病相关死亡风险,尤其在肝硬化患者中1年死亡率更高。
要点
- 慢性HBV感染患者HEV重叠感染与肝病相关死亡风险增加相关
- HBeAg阴性慢性HBV感染亚组中HEV重叠感染是肝病相关死亡、肝硬化及HCC的危险因素
- 肝硬化患者合并HEV重叠感染1年死亡率显著高于无重叠感染者
核心结论
- 在慢性HBV感染患者中,急性HEV重叠感染增加肝病相关死亡风险,尤其在肝硬化患者中更为显著。
研究设计与样本
- 两个独立回顾性队列:非肝硬化队列2123例,肝硬化队列414例,基线HEV-IgG均为阴性,以HEV-IgG血清阳转定义HEV重叠感染。
主要发现
- 非肝硬化队列中2123例有46例发生HEV重叠感染,总体队列中仅与肝病相关死亡发生率增加相关。
- 723例HBeAg阴性慢性HBV感染亚组中,HEV重叠感染是肝病相关死亡、肝硬化和HCC三个终点的危险因素。
- 随访期间发生肝硬化的4例患者HEV重叠感染后1年死亡率为50%,未发生肝硬化者为2.4%(p=0.001)。
- 肝硬化队列中10例HEV重叠感染患者1年死亡率为30%,无重叠感染者为0%(p<0.001)。
临床怎么用
- 对慢性HBV感染患者,尤其肝硬化患者,应关注HEV重叠感染风险并监测肝功能。
局限性
- 回顾性队列设计,HEV重叠感染病例数较少,尤其肝硬化队列仅10例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Acute HEV infection causes varying degrees of liver damage. Although liver-related death due to HEV infection alone is rare in healthy individuals, it is unclear whether HEV superinfection is associated with worse outcomes in patients with chronic HBV infection. Thus, we explored whether HEV superinfection was associated with increased incidence of liver-related death, cirrhosis, and hepatocellular carcinoma (HCC). METHODS: Serum and data were collected from 2 independent retrospective cohorts of patients with chronic HBV infection, comprising 2,123 patients without cirrhosis and 414 with cirrhosis at baseline, respectively. All the patients were negative for HEV-IgG at enrolment and HEV superinfection was defined by the presence of HEV-IgG seroconversion. RESULTS: In the non-cirrhotic cohort, 46 of 2,123 patients developed HEV superinfection. Though HEV superinfection was only associated with increased incidence of liver-related death in the overall cohort, it was a risk factor for all 3 endpoints (liver-related death, cirrhosis, and HCC) in a subgroup of 723 HBeAg-negative patients with chronic HBV infection. In addition, the 1-year mortality rate after HEV superinfection was higher in 4 patients who developed cirrhosis during the follow-up than in those who did not (50% vs. 2.4%, p = 0.001). To elucidate the perceived relationship between HEV superinfection and risk of mortality, an independent cohort of cirrhotic patients (n = 414) was further analyzed to control for the inherent increase in mortality risk due to cirrhosis. The 10 cirrhotic patients with HEV superinfection had a higher 1-year mortality rate than those without (30% vs. 0%, p <0.001). CONCLUSIONS: In both cohorts of patients with chronic HBV infection, acute HEV superinfection increases the risk of liver-related death, especially in those with cirrhosis. LAY SUMMARY: The mortality caused by acute hepatitis E virus infection is usually low in the healthy population, but it is unclear how it affects patients with chronic hepatitis B virus infection, as they already have compromised liver function. Our data show that the 1-year mortality rate is 35.7% in patients with hepatitis B-related cirrhosis who contract hepatitis E virus. Hepatitis E may accelerate disease progression in patients with chronic hepatitis B.
引用
- Tseng TC, Liu CJ, Chang CT, et al. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. J Hepatol. 2020. PMID: 32006586. doi:10.1016/j.jhep.2020.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。